In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 7, 1998, Pages 609-615

  Pourtau, J ^a   Soria, C ^a   Paysant, J ^a   Vannier, J P ^a   Vasse, M ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Atherosclerosis; Oncostatin M; PAI 1; tPA; Von Willebrand factor

Indexed keywords

ONCOSTATIN M; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

EID: 0031744296     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199810000-00007     Document Type: Article

References (28)

1. ECAT Angina Pectoris Study Group. Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factor in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
2. Held C, Hjemdahl P, Rehnqvist N, Wallen NH, Forslund L, Bjorkander I, et al. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the angina prognosis study in Stockholm (APSIS). A comparison with healthy controls. J Int Med 1997; 241: 59-69.
3. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue-type plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74: 626-630.
4. Meade TW. Fibrinogen and ischaemic heart disease. Eur Heart J 1995; 16: 31-35.
5. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111-118.
6. Hamsten A, Wiman B, De Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivor of myocardial infarction. N Engl J Med 1992; 313: 1557-1563.
7. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
8. Vasse M, Collet JP, Soria J, Mirshahi SS, Vannier JP, Soria C. Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion? Thromb Res 1994; 75: 349-352.
9. Grove RI, Eberhardt C, Abid S, Mazzuco C, Liu J, Kiener P, et al. Oncostatin M is mitogen for rabbit vascular smooth muscle cells. Proc Natl Acad Sci USA 1993; 90: 823-827.
10. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, et al. Oncostatin M is a proinflammatory mediator. J Clin Invest 1997; 100: 158-168.
11. Brown JT, Rowe JM, Liu J, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991; 147: 2175-2180.
12. Wojta J, Hoover RL, Daniel TO. Vascular origin determines plasminogen activator expression in human endothelial cells. J Biol Chem 1989; 264: 2846-2882.
13. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-690.
14. Jaffe EA, Nachman RL, Becker CG, Minick R. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756.
15. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Ann Biochem 1976; 72: 248-250.
16. Anfonso F, Alessi MC, Nalbone G, Chomiki N, Henry M, Juhan-Vague I. Up-regulated expression of plasminogen activator inhibitor-1 in HepG2 cells: interrelationship between insulin and insulin-like growth factor 1. Thromb Haemost 1995; 73: 268-274.
17. Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb Haemost 1993; 70: 135-137.
18. Paleolog EM, Crossman DC, McVey JH, Pearson JD. Differential regulation by cytokines of constitutive and stimulated release of von Willebrand factor from endothelial cells. Blood 1990; 75: 688-695.
19. Collins PW, Macey MG, Cahill MR, Newland AC. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb Haemost 1993; 70: 346-350.
20. Woolkalis MJ, DeMelfi TM, Blanchard N, Hoxie JA, Brass LF. Regulation of thrombin receptor on human umbilical vein endothelial cells. J Biol Chem 1995; 270: 9868-9875.
21. Hein L, Ishii K, Coughlin SR, Kobilka BK. Intracellular targeting and trafficking of thrombin receptor. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 1994; 269: 27719-27726.
22. Horvat R, Palade GE. The functional thrombin receptor is associated with the plasmalemma and a large endosomal network in cultured human umbilical vein endothelial cells. J Cell Sci 1995; 108: 1155-1164.
23. Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol 1996; 166: 561-567.
24. Speiser W, Anders E, Preissner KT, Wagner O, Müller-Berghaus G. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins. Blood 1987; 69: 964-967.
25. van Hinsberg VWM. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 1988; 18: 307-327.
26. Ribeiro MJA, Phillips DJ, Benson JM, Evatt BL, Ades EW, Hooper WC. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). Thromb Res 1995; 79: 153-161.
27. de Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, et al. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines -evidences that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1990; 65: 181-185.
28. Nürnberger W, Schneider EM, Michelmann I, Radis F, Scharf RE, Göbel U. Regulation of plasminogen activator inhibitor-1 in microvascular endothelial cells by inflammatory cytokines [abstract]. Fibrinolysis 1996; 10: 43-44.